Discover how precision biotherapeutics can transform healthcare in India by personalizing treatments based on genetic and ...

Guangzhou Focus Biotechnology Co., Ltd., a subsidiary of KHB Group and an innovator in veterinary point-of-care testing (POCT) solutions, presents the enhanced FOCUS PEGASUS MF200 Automatic ...

Intellia Therapeutics (NASDAQ: NTLA) underwent analysis by 21 analysts in the last quarter, revealing a spectrum of ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered ...

Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...

New study has discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad ...

Scientists at the University of Glasgow have successfully used the first bioengineered bone marrow model to carry out vital cancer research, offering new insights into potential therapies for the ...

Technology opens the door to more accurate preclinical testing, which could enable the development of safer and more effective therapies.

Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The ...

In this free webinar, learn how simplifying supply chain management can accelerate the advancement of CRISPR-based therapies, reduce risk and ultimately bring therapies to market faster. Attendees ...

High-rolling investors have positioned themselves bearish on CRISPR Therapeutics (NASDAQ:CRSP), and it's important for retail traders to take note. \This activity came to our attention today through ...

CRISPR can edit DNA like text on a page — a tool powerful enough to cure disease or unleash chaos. Paired with AI, it could save millions… or become the deadliest weapon ever created Mike Johnson ...